TIGIT and malignant colon neoplasm: Moreover, our constructed humanized Tri-NAb (Hu Tri-NAb) targeting human PDL1, 4-1BB, and TIGIT displayed remarkable efficacy against patient-derived colon cancer organoids and effectively suppressed HT-29 human colon cancer growth in humanized mice.